Camellia sinensis in asymptomatic hyperuricemia: A meta-analysis of tea or tea extract effects on uric acid levels

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 2, 2017, Pages 391-398

  Peluso, Ilaria ^a   Teichner, Alessia ^a   Manafikhi, Husseen ^a   Palmery, Maura ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Long term intervention; meta analysis; urate transport; uric acid; xanthine oxidase

Indexed keywords

BIOCHEMISTRY; FLAVONOIDS; POPULATION STATISTICS;

LONG-TERM INTERVENTION; META ANALYSIS; URATE TRANSPORT; URIC ACIDS; XANTHINE OXIDASE;

ORGANIC ACIDS;

ANTIOXIDANT; PLANT EXTRACT; TEA; URIC ACID;

ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; ASYMPTOMATIC DISEASE; BLOOD; CAMELLIA SINENSIS; CARDIOVASCULAR DISEASE; CHEMISTRY; COMPARATIVE STUDY; DIET THERAPY; DIETARY SUPPLEMENT; EVIDENCE BASED MEDICINE; FERMENTATION; FOOD HANDLING; HUMAN; HYPERURICEMIA; META ANALYSIS; MICROBIOLOGY; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLANT LEAF; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; SMOKING; TEA;

ANTIOXIDANTS; ASYMPTOMATIC DISEASES; CAMELLIA SINENSIS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FERMENTATION; FOOD HANDLING; HUMANS; HYPERURICEMIA; OBESITY; OXIDATIVE STRESS; PLANT EXTRACTS; PLANT LEAVES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SMOKING; TEA; URIC ACID;

EID: 84992709179     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2014.889653     Document Type: Article

References (75)

1. U.Axling, C.Olsson, J.Xu, C.Fernandez, S.Larsson, K.Ström, S.Ahrné, C.Holm, G.Molin, and K.Berger, (2012). Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutr. Metab. (Lond). 9(1):105.
2. T.Bahorun, A.Luximon-Ramma, T.T.Gunness, D.Sookar, S.Bhoyroo, R.Jugessur, D.Reebye, K.Googoolye, A.Crozier, and O.O.Aruoma, (2010). Black tea reduces uric acid and C-reactive protein levels in humans susceptible to cardiovascular diseases. Toxicology 278(1):68–74.
3. M.M.Becker, and M.Jolly, (2006). Hyperuricemia and associated diseases. Rheum. Dis. Clin. North Am. 32(2):275–293.
4. P.P.Calder, N.Ahluwalia, F.Brouns, T.Buetler, K.Clement, K.Cunningham, K.Esposito, L.L.Jönsson, H.Kolb, M.Lansink, A.Marcos, A.Margioris, N.Matusheski, H.Nordmann, J.O'Brien, G.Pugliese, S.Rizkalla, C.Schalkwijk, J.Tuomilehto, J.Wärnberg, B.Watzl, and B.B.Winklhofer-Roob, (2011). Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 106(3):S5–S78.
5. H.H.Chow, Y.Cai, I.I.Hakim, J.J.Crowell, F.Shahi, C.C.Brooks, R.R.Dorr, Y.Hara, and D.D.Alberts, (2003). Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 9(9):3312–3319.
6. H.H.Chow, I.I.Hakim, D.D.Vining, J.J.Crowell, C.C.Cordova, W.W.Chew, M.M.Xu, C.C.Hsu, J.Ranger-Moore, and D.D.Alberts, (2006). Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol. Biomarkers. Prev. 15(12):2473–2476.
7. H.H.Chow, I.I.Hakim, D.D.Vining, J.J.Crowell, M.M.Tome, J.Ranger-Moore, C.C.Cordova, D.D.Mikhael, M.M.Briehl, and D.D.Alberts, (2007). Modulation of human glutathione s-transferases by polyphenon e intervention. Cancer Epidemiol. Biomarkers. Prev. 16(8):1662–1666.
8. T.T.Dew, A.A.Day, and M.M.Morgan, (2005). Xanthine oxidase activity in vitro:Effects of food extracts and components. J. Agric. Food Chem. 53(16):6510–6515.
9. A.A.El-Sheikh, J.J.van den Heuvel, J.J.Koenderink, and F.F.Russel, (2008). Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Br. J. Pharmacol. 155(7):1066–1075.
10. H.H.Fink, T.T.Wilt, K.K.Eidman, P.P.Garimella, R.MacDonald, I.I.Rutks, M.Brasure, R.R.Kane, J.Ouellette, and M.Monga, (2013). Medical management to prevent recurrent nephrolithiasis in adults:A systematic review for an American College of Physicians Clinical Guideline. Ann. Intern. Med. 158(7):535–543.
11. H.Fuchikami, H.Satoh, M.Tsujimoto, S.Ohdo, H.Ohtani, and Y.Sawada, (2006). Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug. Metab. Dispos. 34(4):577–582.
12. S.Gomikawa, Y.Ishikawa, W.Hayase, Y.Haratake, N.Hirano, H.Matuura, A.Mizowaki, A.Murakami, and M.Yamamoto, (2008). Effect of ground green tea drinking for 2 weeks on the susceptibility of plasma and LDL to the oxidation ex vivo in healthy volunteers. Kobe. J. Med. Sci. 54(1):E62–E72.
13. S.S.Han, S.S.Han, M.Toborek, and B.Hennig, (2012). EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes. Toxicol. Appl. Pharmacol. 261(2):181–188.
14. S.S.Henning, Y.Niu, Y.Liu, N.N.Lee, Y.Hara, G.G.Thames, R.R.Minutti, C.C.Carpenter, H.Wang, and D.Heber, (2005). Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J. Nutr. Biochem. 16(10):610–616.
15. S.S.Henning, P.Wang, and D.Heber, (2011). Chemopreventive effects of tea in prostate cancer:Green tea versus black tea. Mol. Nutr. Food Res. 55(6):905–920.
16. A.Hesse, R.Siener, H.Heynck, and A.Jahnen, (1993). The influence of dietary factors on the risk of urinary stone formation. Scann. Microsc. 7(3):1119–1127.
17. L.L.Hooper, D.D.Littman, and A.A.Macpherson, (2012). Interactions between the microbiota and the immune system. Science. 336(6086):1268–1273.
18. C.C.Hsu, Y.Y.Liao, S.S.Lin, T.T.Tsai, C.C.Huang, and P.Chou, (2011). Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern. Med. Rev. 16(2):157–163.
19. C.C.Hsu, T.T.Tsai, Y.Y.Kao, K.K.Hwang, T.T.Tseng, and P.Chou, (2008). Effect of green tea extract on obese women:A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 27(3):363–370.
20. Q.Q.Hu, C.Wang, J.J.Li, D.D.Zhang, and L.L.Kong, (2009). Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake:Renal organic ion transporter involvement. Am. J. Physiol. Renal. Physiol. 297(4):F1080–F1091.
21. Q.Q.Hu, X.Zhang, X.Wang, R.R.Jiao, and L.L.Kong, (2012). Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice. Eur. J. Nutr. 51(5):593–606.
22. I.I.Hwang, S.S.Suh, A.A.Suh, and H.H.Ahn, (2011). The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J. Korean Med. Sci. 26(3):386–391.
23. C.C.Hwu, and K.K.Lin, (2010). Uric acid and the development of hypertension. Med. Sci. Monit. 16(10):RA224–RA230.
24. Y.Itoh, T.Yasui, A.Okada, K.Tozawa, Y.Hayashi, and K.Kohri, (2005). Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J. Urol. 173(1):271–275.
25. E.Jówko, J.Sacharuk, B.Balasinska, J.Wilczak, M.Charmas, P.Ostaszewski, and R.Charmas, (2012). Effect of a single dose of green tea polyphenols on the blood markers of exercise-induced oxidative stress in soccer players. Int. J. Sport Nutr. Exerc. Metab. 22(6):486–496.
26. J.Kanellis, D.D.Feig, and R.R.Johnson, (2004). Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton). 9(6):394–399.
27. R.Kawamoto, Y.Tabara, K.Kohara, T.Kusunoki, M.Abe, and T.Miki, (2013). Serum uric acid is more strongly associated with impaired fasting glucose in women than in men from a community-dwelling population. PLoS One. 8(6):e65886.
28. A.Kimura, Y.Ishida, T.Hayashi, T.Wada, H.Yokoyama, T.Sugaya, N.Mukaida, and T.Kondo, (2006). Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am. J. Pathol. 169(4):1118–1128.
29. M.Kimura, K.Umegaki, Y.Kasuya, A.Sugisawa, and M.Higuchi, (2002). The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur. J. Clin. Nutr. 56(12):1186–1193.
30. V.Lahera, M.Goicoechea, S.S.de Vinuesa, P.Oubiña, V.Cachofeiro, F.Gómez-Campderá, R.Amann, and J.Luño, (2006). Oxidative stress in uremia:The role of anemia correction. J. Am. Soc. Nephrol. 7(12 Suppl 3):S174–S177.
31. R.Leenen, A.A.Roodenburg, L.L.Tijburg, and S.S.Wiseman, (2000). A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur. J. Clin. Nutr. 54(1):87–92.
32. L.Li, C.C.Chen, G.Aldini, E.E.Johnson, H.Rasmussen, Y.Yoshida, E.Niki, J.J.Blumberg, R.R.Russell, and K.K.Yeum, (2010). Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults. J. Nutr. Biochem. 21(6):544–549.
33. J.J.Lin, P.P.Chen, C.C.Ho, and S.S.Lin-Shiau, (2000). Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3′-digallate, (−)-epigallocatechin-3-gallate, and propyl gallate. J. Agric. Food Chem. 48(7):2736–2743.
34. N.N.Liptrott, M.Penny, P.P.Bray, J.Sathish, S.S.Khoo, D.D.Back, and A.Owen, (2009). The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br. J. Pharmacol. 156(3):497–508.
35. W.Łuczaj, and E.Skrzydlewska, (2005). Antioxidative properties of black tea. Prev. Med. 40(6):910–918.
36. B.B.Mandell, (2008). Clinical manifestations of hyperuricemia and gout. Cleve. Clin. J. Med. 75(Suppl 5):S5–S8.
37. A.Markel, (2005). Allopurinol-induced DRESS syndrome. Isr. Med. Assoc. J. 7(10):656–660.
38. D.D.Maron, G.G.Lu, N.N.Cai, Z.Z.Wu, Y.Y.Li, H.Chen, J.J.Zhu, X.X.Jin, B.B.Wouters, and J.Zhao, (2003). Cholesterol-lowering effect of a theaflavin-enriched green tea extract:A randomized controlled trial. Arch. Intern. Med. 163(12):1448–1453.
39. S.Martinez-Hervas, J.J.Real, C.Ivorra, A.Priego, F.F.Chaves, F.F.Pallardo, J.J.Viña, J.Redon, R.Carmena, and J.J.Ascaso, (2010). Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia. Nutr. Metab. Cardiovasc. Dis. 20(10):734–739.
40. T.T.Mikuls, J.J.Farrar, W.W.Bilker, S.Fernandes, and K.K.Saag, (2005). Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia:Results from the UK General Practice Research Database (GPRD). Rheumatol. (Oxford). 44(8):1038–1042.
41. D.Moher, A.Liberati, J.Tetzlaff, D.D.Altman, PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses:The PRISMA statement. PLoS Med. 6:e1000097.
42. N.Müller, S.Ellinger, B.Alteheld, G.Ulrich-Merzenich, H.H.Berthold, H.Vetter, and P.Stehle, (2010). Bolus ingestion of white and green tea increases the concentration of several flavan-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers. Mol. Nutr. Food Res. 54(11):1636–1645.
43. F.Natella, M.Nardini, I.Giannetti, C.Dattilo, and C.Scaccini, (2002). Coffee drinking influences plasma antioxidant capacity in humans. J. Agric. Food Chem. 50(21):6211–6216.
44. M.Nomura, W.Ma, N.Chen, A.A.Bode, and Z.Dong, (2000). Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (−)-epigallocatechin gallate and theaflavins. Carcinogenesis. 21(10):1885–1890.
45. C.C.Palermo, C.C.Westlake, and T.T.Gasiewicz, (2005). Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry. 44(13):5041–5052.
46. V.V.Panza, E.Wazlawik, G.Ricardo Schütz, L.Comin, K.K.Hecht, and E.E.da Silva, (2008). Consumption of green tea favorably affects oxidative stress markers in weight-trained men. Nutrition. 24(5):433–442.
47. A.A.Park, and Z.Dong, (2003). Signal transduction pathways:Targets for green and black tea polyphenols. J. Biochem. Mol. Biol. 36(1):66–77.
48. I.Peluso, A.Raguzzini, and M.Serafini, (2013). Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans:A systematic review and meta-analysis. Mol. Nutr. Food Res. 57(5):784–801.
49. H.H.Princen, W.van Duyvenvoorde, R.Buytenhek, C.Blonk, L.L.Tijburg, J.J.Langius, A.A.Meinders, and H.Pijl, (1998). No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler. Thromb. Vasc. Biol. 18(5):833–841.
50. A.Rabovsky, J.Cuomo, and N.Eich, (2006). Measurement of plasma antioxidant reserve after supplementation with various antioxidants in healthy subjects. Clin. Chim. Acta. 371(1–2):55–60.
51. S.S.Rodrigues, M.M.Baldo, P.Capingana, P.Magalhães, E.E.Dantas, C.Molina Mdel, L.L.Salaroli, R.R.Morelato, and J.J.Mill, (2012). Gender distribution of serum uric acid and cardiovascular risk factors:Population based study. Arq. Bras. Cardiol. 98(1):13–21.
52. M.Rondanelli, A.Opizzi, S.S.Solerte, R.Trotti, C.Klersy, and R.Cazzola, (2009). Administration of a dietary supplement (N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects:A randomized controlled trial. Br. J. Nutr. 101(3):457–464.
53. M.Roth, B.B.Timmermann, and B.Hagenbuch, (2011). Interactions of green tea catechins with organic anion-transporting polypeptides. Drug. Metab. Dispos. 39(5):920–926.
54. T.Sekine, H.Miyazaki, and H.Endou, (2006). Molecular physiology of renal organic anion transporters. Am. J. Physiol. Renal. Physiol. 290(2):F251–F261.
55. M.Serafini, D.Del Rio, D.D.Yao, S.Bettuzzi, and I.Peluso, (2011a). Health benefits of tea. In:Herbal Medicine:Biomolecular and Clinical Aspects. 2nd ed. Chapter 12. pp. 239–262. I.F.F.Benzie, and S.Wachtel-Galor, Eds., CRC Press, Boca Raton, FL.
56. M.Serafini, C.Miglio, I.Peluso, and T.Petrosino, (2011b) Modulation of plasma non enzimatic antioxidant capacity (NEAC) by plant foods:The role of polyphenols. Curr. Top. Med. Chem. 11(14):1821–1846.
57. Y.Shi, J.J.Evans, and K.K.Rock, (2003). Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 425:516–521.
58. T.Sone, S.Kuriyama, N.Nakaya, A.Hozawa, T.Shimazu, K.Nomura, S.Rikimaru, and I.Tsuji, (2011). Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr. Res. 55. doi:10.3402/fnr.v55i0.8326.
59. P.Strazzullo, and J.J.Puig, (2007). Uric acid and oxidative stress:Relative impact on cardiovascular risk? Nutr. Metab. Cardiovasc. Dis. 17(6):409–414.
60. K.Sugihara, S.Kitamura, T.Yamada, S.Ohta, K.Yamashita, M.Yasuda, and Y.Fujii-Kuriyama, (2001). Aryl hydrocarbon receptor (AhR)-mediated induction of xanthine oxidase/xanthine dehydrogenase activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Biophys. Res. Commun. 281(5):1093–1099.
61. A.A.Tausche, T.T.Jansen, H.H.Schröder, S.S.Bornstein, M.Aringer, and U.Müller-Ladner, (2009). Gout–current diagnosis and treatment. Dtsch. Arztebl. Int. 106(34–35):549–555.
62. J.J.Tayar, M.M.Lopez-Olivo, and M.M.Suarez-Almazor, (2012). Febuxostat for treating chronic gout. Cochrane. Database Syst. Rev. 11:CD008653.
63. E.E.Taylor, and G.G.Curhan, (2006). Diet and fluid prescription in stone disease. Kidney Int. 70(5):835–839.
64. V.Tremaroli, and F.Bäckhed, (2012). Functional interactions between the gut microbiota and host metabolism. Nature. 489(7415):242–249.
65. J.J.Vaidyanathan, and T.Walle, (2001). Transport and metabolism of the tea flavonoid (−)-epicatechin by the human intestinal cell line Caco-2. Pharm. Res. 18(10):1420–1425.
66. J.J.Van Amelsvoort, K.K.Van Hof, J.J.Mathot, T.T.Mulder, A.Wiersma, and L.L.Tijburg, (2001). Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica. 31(12):891–901.
67. K.K.van het Hof, H.H.de Boer, S.S.Wiseman, N.Lien, J.J.Westrate, and L.L.Tijburg, (1997). Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 66(5):1125–1132.
68. G.Vischini, P.Niscola, A.Stefoni, and F.Farneti, (2011). Increased plasma levels of tacrolimus after ingestion of green tea. Am. J. Kidney Dis. 58(2):329.
69. C.C.Wang, X.Wang, X.Zhang, Y.Y.Shi, L.Liu, and L.L.Kong, (2010). Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice. J. Pharm. Pharm. Sci. 13(3):411–427.
70. H.Wang, Y.Wei, X.Kong, and D.Xu, (2013). Effects of urate-lowering therapy in hyperuricemia on slowing the progression of renal function:A meta-analysis. J. Ren. Nutr. 23(5):389–396.
71. Z.Yin, E.E.Henry, and T.T.Gasiewicz, (2009). (−)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry. 48(2):336–345.
72. T.Yokozawa, D.D.Rhyu, and E.E.Cho, (2004). (−)-Epicatechin 3-O-gallate ameliorates the damages related to peroxynitrite production by mechanisms distinct from those of other free radical inhibitors. J. Pharm. Pharmacol. 56(2):231–239.
73. Z.Yu, W.W.Fong, and C.C.Cheng, (2007). Morin (3,5,7,2′,4′-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells. Drug. Metab. Dispos. 35(6):981–986.
74. M.M.Zhang, Y.Y.Gao, X.Wang, H.Chang, and G.G.Huang, (2013). Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among Chinese adults. J. Clin. Biochem. Nutr. 52(1):38–42.
75. G.Zoppini, G.Targher, and E.Bonora, (2011). The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects:A narrative review. J. Endocrinol. Invest. 34(11):881–886.